OrderlyMeds announces an online eligibility calculator for GLP-1 weight loss medications. The tool provides immediate qualification assessment based on BMI and comorbidity criteria, plus personalized calorie and protein targets for users.
-- OrderlyMeds has introduced an online eligibility calculator to help individuals determine whether they qualify for GLP-1 medications for weight loss. The tool addresses a common barrier for those considering this treatment option by providing immediate clarity on medical requirements. Users receive a personalized weight loss guide that includes tailored daily calorie and protein targets endorsed by OrderlyMeds customers who have reported significant weight loss results.
More information is available at https://patients.orderlymeds.com/eligibility
Anecdotal reports of weight loss while using GLP-1 medications are backed by clinical data, which shows that semaglutide produces an average of 17.4 percent total body weight loss, while tirzepatide averages approximately 22.5 percent. The calculator emphasizes protein targets and lifestyle modification because clinical trials have demonstrated that patients often regain two-thirds of their lost weight within one year of discontinuing medication without establishing lasting habits. This underscores the importance of integrating medically guided behavioral change alongside pharmaceutical intervention.
Standard medical criteria for GLP-1 qualification require a Body Mass Index of 30 or higher, or a BMI of 27 or higher accompanied by at least one weight-related comorbidity such as high blood pressure, high cholesterol, or type 2 diabetes, explains Orderly Meds. However, many individuals remain uncertain about their eligibility. The calculator addresses this uncertainty by offering an accessible assessment based on established regulatory standards.
The calculator generates a personalized weight loss guide with specific daily calorie and protein recommendations. General guidelines suggest approximately 1,200 calories per day for women and 1,500 for men under medical supervision, supporting safe weight loss targets of one to two pounds per week.
The calculator also serves as the entry point to OrderlyMeds' GLP-1 program, which includes compounded semaglutide or compounded tirzepatide, both available with a 3-month starter program. Monthly plans for those already taking GLP-1 medication and branded options such as Zepbound and Wegovy are also offered through the platform. OrderlyMeds operates a licensed provider network spanning all 50 states, ensuring accessibility regardless of geographic location.
For more details, visit https://orderlymeds.com/
Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/
Source: PressCable
Release ID: 89188905
In case of identifying any errors, concerns, or inconsistencies within the content shared in this press release that necessitate action or if you require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team is committed to addressing your concerns within 8 hours by taking necessary actions diligently to rectify any identified issues or supporting you with the removal process. Delivering accurate and reliable information remains our top priority.
